| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4183173 | L'Encéphale | 2007 | 8 Pages |
Abstract
Results from clinical trials demonstrated that atomoxetine is effective and well tolerated for the acute and long-term treatment of children and adolescents suffering from ADHD. Atomoxetine should be considered as a new interesting pharmacological option in the treatment of ADHD in association with non pharmacological therapeutic interventions.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
C. Gaillez, F. Sorbara, E. Perrin,